Real-time enrollment status for this drug resistant epilepsy clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 3:27 PM UTC
| NCT Number | NCT07546253 |
| Recruiting Status | Recruiting |
| Condition | Drug Resistant Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 3 sites in the US |
| Sponsor | NeuroOne Medical Technologies Corporation |
| Last Updated on CT.gov | October 16, 2026 (15 hours ago) |
As of October 16, 2026: Clinical trial NCT07546253 is currently recruiting participants. This clinical trial study for drug resistant epilepsy is actively seeking new participants at 3 locations across the United States. The study is sponsored by NeuroOne Medical Technologies Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07546253 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07546253 was last updated 15 hours ago (October 16, 2026). HelloStudys verifies this status automatically.